Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ad Scientiam
Paris, France
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
Ad Scientiam develops and commercializes CE‑marked software medical devices that collect real‑world patient data via smartphones to derive clinically validated digital biomarkers, exemplified by MSCopilot for multiple sclerosis; its tools are used in clinical practice and in clinical trials in partnership with pharma companies.[2][5]
- Therapeutic areas
- PsychiatryImmunologyNeurology
- Modalities
- DeviceNon-pharmacological therapySoftware as a Medical Device
- Industry
- Digital Health Medical Devices
02
Partnerships
Roche France[2]Alexion[5]Abata Therapeutics[5]
Beyond the preview
Go deeper on Ad Scientiam.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ad Scientiam.